Breast carcinomas from premenopausal patients showed a lower percentage of ERα-positive cells (12.2 ± 19%) than those from postmenopausal patients (42.3 ± 35.5%; Mann–Whitney test, P = 0.021). Here, ESR1 is linked to breast carcinoma.